Growing presence – based on innovation

We are acquiring Qlight Nanotech Ltd., Jerusalem, Israel. “The acquisition of Qlight Nanotech perfectly fits into our innovation strategy as innovations are our lifeblood,” said Karl-Ludwig Kley, CEO and Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany.

Merck KGaA, Darmstadt, Germany Invests € 30 Million in New OLED Production Plant in Darmstadt

Starting in July 2016, materials for modern flat screens and lighting systems will be produced at a new OLED production plant. Merck, KGaA, Darmstadt, Germany, is investing around 30 million euros in the new building at its headquarters in Darmstadt.

Taking Science Further Faster

EMD Millipore has introduced the Mobius 2000 Liter Single-Use Bioreactor at this year’s ACHEMA in Frankfurt to help customers optimize their upstream processes. Bioreactors are used to grow microorganisms or cells in an ideal environment. 

What`s the best way for our company to grow around the world - 125 Years in the U.S.

"We must clearly understand that ...the focus of our business will be here in America. America is the country of the future (and) will...supply the world market with many of the products from our industrie."
(Georg Merck)

Asco 2015 - Welcoming Collaboration, Driving Innovation

“We are eager to share the latest early data for avelumab at ASCO,” said Belén Garijo, Member of our executive Board and CEO Healthcare, “this is the first time we will be presenting data on avelumab as an alliance. And we are making good progress with our Evofosfamide drug candidate for the possible treatment of pancreatic cancer as well as soft tissue sarcoma.”

Global Strategic Alliance with Pfizer on Anti-PD-L1 to Accelerate Presence in Immuno-Oncology

November 17, 2014 – Merck KGaA, Darmstadt, Germany, and Pfizer entered into a global agreement to co-develop and co-commercialize our investigational anti-PD-L1 antibody as a potential treatment for multiple tumor types to accelerate the two companies’ presence in immuno-oncology.
As part of the agreement, Merck KGaA, Darmstadt, Germany, will co-promote Pfizer’s Xalkori, a medicine to treat non-small cell lung cancer, in the United States and several other key markets.

 

Media Services for the US and Canada – News starting 2013, Dates & Publications

Latest Press Releases
Growing presence – based on innovation
Growing presence – based on innovation
Darmstadt, Germany, June 29, 2015 – We are acquiring Qlight Nanotech Ltd., Jerusalem, Israel. “The acquisition of Qlight Nanotech perfectly fits into our innovation strategy as innovations are our lifeblood,” said Karl-Ludwig Kley, CEO and Chairman of the Executive Board of Merck KGaA, Darmstadt, Germany.
 
OLED
Merck KGaA, Darmstadt, GermanyInvests € 30 Million in New OLED Production Plant in Darmstadt
Darmstadt, Germany, June 19, 2015 – Merck KGaA, Darmstadt, Germany laid the cornerstone for a new OLED materials production plant in Darmstadt today. Production of high-purity OLED materials for use in state-of-the-art displays and lighting systems is scheduled to start in the approximately 2,000 square meter building in July 2016. With the investment, which amounts to around € 30 million, our company is strengthening its position in the OLED business.
 
Acquisition of Sigma-Aldrich Receives Clearance from EU Regulators – Approvals Also Granted by Japan and China
Merck KGaA, Darmstadt, Germany’s Acquisition of Sigma-Aldrich Receives Clearance from EU Regulators – Approvals Also Granted by Japan and China
Darmstadt, Germany, June 15, 2015 – Merck KGaA, Darmstadt, Germany, today announced that the European Commission has approved its planned acquisition of U.S.-based life science company Sigma-Aldrich.
 
 
top

OUR COMPANY IN THE MEDIA

OUR COMPANY IN THE MEDIA
Read how Merck KGaA, Darmstadt, Germany, and its affiliates are covered by media outlets around the world

DOWNLOAD LIBRARY

Download Library
Download images, Media Kits and other material from our media download library

CALENDAR OF EVENTS

Calendar of Events
Find and register for upcoming events

DISCLAIMER

Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD. To reflect such fact and to avoid any misconception of the reader of the publication certain logos, terms and business descriptions of the publication have been substituted or additional descriptions have been added. Publications on this homepage, therefore, slightly deviate from the otherwise identical version of the publications provided outside the United States and Canada.
 

CONTACTS FOR JOURNALIST INQUIRIES

Media Team
POSTAL ADDRESS 
Merck KGaA 
Frankfurter Straße 250 
64293 Darmstadt 
Germany
Tel.: +49 6151 72-5000
Fax: +49 6151 72-3138
 

GENERAL INQUIRIES

Communications Center
Tel.: +49 6151 72-0
Fax: +49 6151 72-2000
 

FINANCIAL REPORT ON Q1 2015

Merck Financial Report
Merck on Facebook
Twitter
 
  
Read more on M - The Explorer Magazine

A world-renowned baby

Elizabeth Carr was America’s first test-tube baby. A medicine from our company helped make her sensational birth possible in 1981. Elizabeth was followed by millions of other babies.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Bike MS: Riding for a good cause

Cycling with a long tradition: The Cape Cod Getaway (CCG) will take place for the 11th time at the end of June. The event is part of the Bike MS® fundraising cycling series.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Discovering the New World

An innovation-friendly environment and business opportunities — the preconditions for success are more favorable in the United States than just about anywhere else.

Read more on M - The Explorer Magazine